Gravar-mail: GUIDANCE OF GANCICLOVIR THERAPY WITH pp65 ANTIGENEMIA IN CYTOMEGALOVIRUS-FREE RECIPIENTS OF LIVERS FROM SEROPOSITIVE DONORS